Yao‐Yu Hsieh

EZH2 inhibitors transcriptionally upregulate cytotoxic autophagy and cytoprotective unfolded protein response in human colorectal cancer cells.

Yao‐Yu Hsieh, Hsiang-Ling Lo, Pei‐Ming Yang · PubMed · 2016 · 46 citations · Full text

Chemoprevention Strategy, Cell Death, Cancer Biology +16

Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma

Hao‐Wei Teng, Hsei–Wei Wang, Wei‐Ming Chen et al. · Journal of Surgical Oncology · 2011 · 38 citations

Epidermal growth factor receptor <scp>R</scp>521<scp>K</scp> polymorphism shows favorable outcomes in <scp><i>KRAS</i></scp> wild‐type colorectal cancer patients treated with cetuximab‐based chemotherapy

Yao‐Yu Hsieh, Cheng‐Hwai Tzeng, Ming‐Huang Chen et al. · Cancer Science · 2012 · 30 citations · Full text

Cetuximab‐based Chemotherapy, Tumor Biology, Medicine +15

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer

Tom Wei‐Wu Chen, Ming‐Shen Dai, Ling‐Ming Tseng et al. · JAMA Oncology · 2023 · 25 citations · Full text

Comparing the effectiveness of different EGFR‐TKIs in patients with EGFR mutant non–small‐cell lung cancer: A retrospective cohort study in Taiwan

Yao‐Yu Hsieh, Wei‐Tse Fang, Yu‐Wen Lo et al. · International Journal of Cancer · 2019 · 18 citations · Full text

Retrospective Cohort Study, Iv Nsclc, Tumor Microenvironment +14